Cel-Sci
CVM
#9766
Rank
ยฃ38.7 M
Marketcap
ยฃ4.84
Share price
2.54%
Change (1 day)
-63.23%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ9.99 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are ยฃ9.99 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30ยฃ10.55 M-25.61%
2023-09-30ยฃ14.19 M-13.97%
2022-09-30ยฃ16.5 M14.95%
2021-09-30ยฃ14.35 M-10.89%
2020-09-30ยฃ16.1 M-11.96%
2019-09-30ยฃ18.29 M-19.35%
2018-09-30ยฃ22.69 M15.75%
2017-09-30ยฃ19.6 M-0.61%
2016-09-30ยฃ19.72 M-10.46%
2015-09-30ยฃ22.02 M306.47%
2014-09-30ยฃ5.41 M111.97%
2013-09-30ยฃ2.55 M-54.4%
2012-09-30ยฃ5.6 M-8.29%
2011-09-30ยฃ6.11 M-3.45%
2010-09-30ยฃ6.33 M-72.93%
2009-09-30ยฃ23.38 M975.73%
2008-09-30ยฃ2.17 M-26.67%
2007-09-30ยฃ2.96 M-47.55%
2006-09-30ยฃ5.65 M908.52%
2005-09-30ยฃ0.56 M-27.53%
2004-09-30ยฃ0.77 M-23.73%
2003-09-30ยฃ1.01 M-41.6%
2002-09-30ยฃ1.73 M403.46%
2001-09-30ยฃ0.34 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
ยฃ31.77 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.62 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ60.44 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.18 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.47 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
ยฃ85.22 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.65 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ1.95 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA